Puma Biotechnology
PBYI on XNAS, PUMA BIOTECHNOLOGY INC
Measures activity, not value. Not investment advice.
Latest month (Jun 2020)
-$79K
-10.0× the 3-year median
Last 12 months
-$79K
vs the 12 months before
Sharp changes
0
federal obligations jump, first federal award, first award from a new federal agency
What usually follows Federal contracts growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it
USAspending.gov obligations by date. Dashed: 3-year median.
See the numbers
| Month of Jun 2020: -$79K |
| Month of Jun 2018: $95K |
| Month of May 2018: $24.2 |
| Month of Apr 2018: $16K |
| Month of Mar 2018: $8K |
| Month of Jan 2018: $8K |
What the numbers say
- Federal obligations: -$79K in June 2020, -10.0× the 3-year median; the most since Jun 2018.
Sharp changes
0 in all loaded history, strongest first
No sharp change of this kind in all loaded history.
The records
Newest first, by the day each became public
No records in all loaded history with these filters.